At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 50 enrolled
Drug / intervention
Nebulized magnesium sulfatedrug
Likely dose
Nebulized magnesium sulfate 15 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Nebulized Magnesium Sulfate Versus Normal Saline as a Vehicle for Albuterol in Children With Moderate to Severe Asthma Exacerbation: a Randomized Controlled Trial
University of Texas Southwestern Medical Center·interventional·Posted Jan 24, 2012·Updated Feb 21, 2019
In Brief
A Phase 4 clinical trial evaluating Nebulized magnesium sulfate for Asthma. Completed, enrolled 50 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the effectiveness of nebulized magnesium sulfate as a vehicle for albuterol in children with moderate to severe asthma exacerbation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2012
First PostedJan 2012
Primary CompletionOct 2015
TodayJul 2026
First PostedJan 24, 2012
Enrollment StartJan 1, 2012
Primary CompletionOct 1, 2015
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 14.4 years ago
Interventions
Nebulized magnesium sulfatedrug
15 mg albuterol in 22 ml of magnesium sulfate solution (880 mg) via nebulizer over one hour Versus 15 mg albuterol in 22 ml of normal saline via nebulizer over one hour